To screen ETFs by asset class, performance, yield and more, check out the
) looks attractive at these prices... but one must consider patent expiration and their research...
Add a reply...
Latest StockTalks »
people get AZN breaking news and analysis by email alert.
Get email alerts on AZN »
AstraZeneca Group plc
Get latest price
From other sites
Ardelyx Regains Product Portfolio Rights from AstraZeneca - Analyst Blog
at Zacks.com (Jun 4, 2015)
AstraZeneca Presents Data at ASCO; Inks Deal with Eli Lilly - Analyst Blog
at Zacks.com (Jun 1, 2015)
London Markets: FTSE 100 climbs, with AstraZeneca rising after drug update
at MarketWatch.com (Jun 1, 2015)
Europe shares higher, China data buoys; AstraZeneca gains
at CNBC.com (Jun 1, 2015)
The Zacks Analyst Blog Highlights: Johnson & Johnson, AstraZeneca, ACADIA Pharmaceuticals, Actavis and Alkermes - Press Releases
at Zacks.com (May 26, 2015)
Xignite quote data
© 2015 Seeking Alpha